Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 16;12:666561. doi: 10.3389/fgene.2021.666561

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Ban, Yang, Wei, Liu, Wang, Chen, Lu, Xie, Liu and Huang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Clinical characteristics in low mRNAsi and high mRNAsi MM patients. (A,B) Differences in mRNAsi between distinct B2M groups (A) and isotype groups (B) in patients with MM. The upper and lower ends of the boxes represent the interquartile range of values. The lines in the boxes represent median values. (C,D) Difference in mRNAsi between distinct subgroups (C) and cytogenetic abnormalities groups (D) in patients with MM. (E,F) Difference in mRNAsi between distinct treatment regimen groups in patients of the GSE24080 cohort (E) or the GSE4204 cohort (F). (G,H) Difference in stromalscore and immunescore between high and low mRNAsi samples of the GSE24080 cohort (G) or the GSE4204 cohort (H). ****p < 0.0001.